Jing Dianna Qian

Pivotal Bioventure Partners Investment Advisor LLC (Pivotal Bioventure) is a venture capital firm founded in 2017 by Vincent Cheung. The firm is headquartered in San Francisco, California.

Nan Fung Life Sciences (Nan Fung Life Sciences) is a venture capital subsidiary of Vervain Group (Holdings) Ltd founded in 1954 by Vincent Cheung. The firm is headquartered in Hong Kong.

Invest Hong Kong provides investment promotion, facilitation, and aftercare services. It offers services in the financial services, technology, telecommunications, and tourism and transportation sectors. The company was founded in July 2000 and is headquartered in Hong Kong.

The Johns Hopkins Hospital, Inc. provides healthcare services. The hospital is affiliated to the Johns Hopkins University School of Medicine. It offers inpatient and outpatient health services that include general medicine, emergency and trauma care, pediatrics, maternity, and senior care. The company was founded in 1889 and is headquartered in Baltimore, MD.

Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life.

Engrail Therapeutics, Inc. acquires, develops and commercialize transformative medicines. The company was founded in 2019 and is headquartered in San Diego, CA.

Hangzhou Qihan Biotech Co., Ltd. is a biotech company that applies genome-editing technology to develop novel cell therapies and organs for transplantation. The company is based in Hangzhou, China. The Chinese company's mission is to create immunologically privileged allogeneic cells and xenogeneic organs for use as therapies to treat cancer, organ failure, and other complex medical conditions. Qihan Biotech has raised two rounds of financing and is advancing its cell therapy programs into IND enabling investigations. It was founded in 2017 by Luhan Yang and George McDonald Church, with Luhan Yang serving as the CEO since then.

Berkeley Frontier Fund (Berkeley Frontier Fund) is a venture capital firm founded in 202. The firm is headquartered in Berkeley, California.

Founded in 1985, Barclays Capital Asia Ltd. is a Chinese brokerage services company. Part of Barclays PLC, the company is based in Hong Kong, Hong Kong.

Citigroup Global Markets Asia Ltd. (CGMA) is a securities brokerage firm headquartered Hong Kong. They are a subsidiary of Citigroup Global Markets Hong Kong Holdings Ltd., ultimately owned by Citigroup, Inc. (NYSE: C) in the US. Formerly known as Citi Smith Barney, the firm was reorganized in 2008 when Citigroup combined their brokerage and private banking businesses. CGMA offers stock trading services to various institutional investors.

BioSymetrics, Inc. develops an artificial intelligence and machine learning data science software solutions. It offers a SaaS-based biomedical Machine Learning (ML) platform, Augusta, that enables customers to perform automated ML and data pre-processing. Augusta?s automated iteration framework addresses the step in ML that is time consuming and error-prone, that of cleaning and pre-processing unstructured data for analysis. The company was founded by Anthony Iacovone in 2015 and is headquartered in Toronto, Canada.

Tallwood Venture Capital (Tallwood Venture Capital) is a venture capital firm founded in 1999 by Diosdado P. Banatao. The firm is headquartered in Palo Alto, California.

Qualcomm Atheros, Inc. provides wireless and wired technologies for the mobile, networking, computing and consumer electronics markets. The company was founded in May 1998 and is headquartered in San Diego, CA.

Vidyo, Inc. provides video conferencing solutions. Its services include adoption, deployment, project management, and telehealth clinical design. The firm's products include mobile, desktop, huddle room and board room. Its core capabilities include management and call control, media routing and optimization, recording and webcasting, and interoperability. The company was founded by Tal Dilian, Ofer Shapiro, Isaac Levy, Avery More, and Alexandros Eleftheriadis and in 2005 and is headquartered in Hackensack, NJ.

Grove Ventures Capital (GP) Ltd (Grove Ventures) is a venture capital firm founded in 2015. The firm is headquartered in Tel Aviv, Israel.

Provigent Ltd. engages in the development of wireless broadband communication chips. The company was founded by Dan Charash and Guy Resheff in 2000 and is headquartered in Herzliya, Israel.

Sanofi-Aventis U.S. LLC engages in the provision of pharmaceutical products. It discovers, develops, produces and markets innovative therapies. The firm extensive research and development efforts are focused on health care challenges in cardiology, oncology and internal medicine, as well as metabolic diseases, central nervous system disorders, ophthalmology and vaccines. The company is headquartered in Bridgewater, NJ.

Avalyn Pharma, Inc. manufactures pharmaceutical products. It develops improved therapies for the treatment of idiopathic pulmonary fibrosis (IPF) and other severe respiratory diseases. The company was founded by Richard Glenn Vincent and Mark W. Surber in 2011 and is headquartered in Seattle, WA.

Israel Advanced Technology Industries is an umbrella organization that represents the high-tech, life science, and other advanced technology industries. The private company is based in Hertzliya Pituach, Israel. The Israeli company was founded by Nechemia Jacob Peres, Aaron Mankovski, and Ruth Alon. The CEO is Karin Meir Rubinstein.

Arctic Vision (Shanghai) Biotechnology Co., Ltd. is a Chinese Shanghai-based ophthalmic biotech company that focuses on developing innovative therapies to address unmet clinical needs and benefit ophthalmic patients. The company is led by an elite team of ophthalmic industry veterans with substantial experience in R&D and commercialization of eye care products. Arctic Vision has top-tier biotech venture capital investors with a broad network in both the U.S. and European ophthalmic markets, and an unprecedented track record in company incubation. The company was founded by Hai Di Hu, who has been the CEO since incorporation.

Oncxerna Therapeutics, Inc. develops oncology drugs. The firm uses RNA-based biomarker platform. It focuses on clinical-stage therapies. The company was founded by Laura E. Benjamin in 2018 and is headquartered in Boston, MA.

KPCB China Fund II LP seeks investment opportunities in companies located in China. The fund focuses on companies operating in the fields of health technology, industrial services, and technology services sectors.. It provides financing for seed, early and later-stage capital requirements.

Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016.